Table 2.
Univariate Logistic Regression Analysis for Risk Factors with Poor Functional Prognosis
| Variable | Poor Functional Outcome (mRS Score 3–6) | |
|---|---|---|
| OR (95% CI) | P values | |
| Demographic | ||
| Age, years | 1.016[1.003–1.030] | P=0.018 |
| Male | 0.685[0.494–0.950] | P=0.023 |
| Smoker | 0.863[0.614–1.214] | P=0.399 |
| Alcohol user | 0.721[0.499–1.040] | P=0.080 |
| Clinical features | ||
| Hospitalization days | 1.077[1.038–1.118] | P<0.001 |
| SBP | 1.000[0.997–1.003] | P=0.869 |
| DBP | 0.999[0.989–1.010] | P=0.919 |
| Admission NIHSS score | 1.375[1.300–1.455] | P<0.001 |
| Laboratory data | ||
| TC | 0.960[0.840–1.096] | P=0.547 |
| TG | 0.891[0.747–1.063] | P=0.199 |
| HDL | 1.132[0.576–2.226] | P=0.719 |
| LDL | 1.019[0.841–1.234] | P=0.851 |
| GLU | 1.019[0.960–1.081] | P=0.546 |
| NLR | 1.101[1.049–1.156] | P<0.001 |
| PLR | 1.003[1.002–1.005] | P<0.001 |
| LMR | 0.783[0.705–0.869] | P<0.001 |
| SIRI | 1.144[1.055–1.240] | P=0.001 |
| Medical history | ||
| Hypertension | 0.981[0.695–1.385] | P=0.914 |
| Diabetes | 1.130[0.797–1.603] | P=0.493 |
| Stroke | 1.560[1.115–2.184] | P=0.010 |
| Atrial fibrillation | 1.451[0.726–2.900] | P=0.293 |
| Coronary heart disease | 1.185[0.702–1.998] | P=0.526 |
| Medication use history | ||
| Lipid lowering drugs | 1.058[0.674–1.660] | P=0.805 |
| Hypoglycemic drugs | 1.370[0.941–1.994] | P=0.101 |
| Antihypertensive drugs | 0.940[0.680–1.299] | P=0.709 |
| Antiplatelet drugs | 1.080[0.723–1.613] | P=0.706 |
| Thrombolysis | 1.844[0.947–3.590] | P=0.072 |
| TOAST classification | 0.552[0.413–0.738] | P<0.001 |
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; NIHSS, National Institute of Health Stroke Scale; TC, total cholesterol; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein; GLU, Plasma glucose; NLR, neutrophil-lymphocyte ratio; PLR, platelet-lymphocyte ratio; LMR, lymphocyte-monocyte ratio; SIRI, systemic inflammation response index.